Systems Engineering for Viral Vector Manufacturing
Gene therapies have emerged in recent years as a great promise for treatments against a variety of otherwise difficult to treat diseases. Recombinant adeno-associated virus (rAAV) is the current vehicle of choice for in vivo gene therapy treatments for its reduced toxicity, robust and long-term tran...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Published: |
Massachusetts Institute of Technology
2023
|
| Online Access: | https://hdl.handle.net/1721.1/150243 |